AstraZeneca is shifting production of its COVID-19 vaccine away from a plant in Baltimore which also makes Johnson & Johnson's shot, after human error resulted in the contamination of 1
The head of the EMA has reiterated that there is no evidence to limit the use of AstraZeneca's COVID-19 vaccine in any age group, after Germany and Canada imposed restrictions in younger pa
In the latest episode of the pharmaphorum podcast Dominic Tyer speaks with GlaxoSmithKline’s Philip Cruz about the discovery and commercialisation of new vaccines in the light of the pandem